Administration-time differences in effects of hypertension medications on ambulatory blood pressure regulation.
about
Gentamicin-induced ototoxicity and nephrotoxicity vary with circadian time of treatment and entail separate mechanisms.Influence of the cardiomyocyte circadian clock on cardiac physiology and pathophysiology.Optimising the accuracy of blood pressure monitoring in chronic kidney disease: the utility of BpTRUAmbulatory blood pressure monitoring in clinical practice: a review.Ambulatory Blood Pressure in Chronic Kidney Disease: Ready for Prime Time?Twenty-four-hour patterns in occurrence and pathophysiology of acute cardiovascular events and ischemic heart disease.Dipper and non-dipper blood pressure 24-hour patterns: circadian rhythm-dependent physiologic and pathophysiologic mechanisms.Chronotherapy improves blood pressure control and reduces vascular risk in CKD.Epidemiology, prognosis, and treatment of resistant hypertension.Chronotherapeutics of conventional blood pressure-lowering medications: simple, low-cost means of improving management and treatment outcomes of hypertensive-related disorders.Sleep-time ambulatory blood pressure as a novel therapeutic target for cardiovascular risk reduction.Use of ambulatory blood pressure measurement in the definition of resistant hypertension: a review of the evidence.Around-the-clock ambulatory blood pressure monitoring is required to properly diagnose resistant hypertension and assess associated vascular risk.Bedtime ingestion of hypertension medications reduces the risk of new-onset type 2 diabetes: a randomised controlled trial.One-size-fits-all management of hypertension: a key to poor control of hypertension in low income settings in sub-Saharan Africa?2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals.Ambulatory blood pressure monitoring: importance of sampling rate and duration--48 versus 24 hours--on the accurate assessment of cardiovascular risk.Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction.Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes.Sleep-Time Ambulatory BP Is an Independent Prognostic Marker of CKD.Sleep-time ambulatory blood pressure as a prognostic marker of vascular and other risks and therapeutic target for prevention by hypertension chronotherapy: Rationale and design of the Hygia Project.Chronotherapy with conventional blood pressure medications improves management of hypertension and reduces cardiovascular and stroke risks.Elevated asleep BP as predictor of type 2 diabetes and therapeutic target for prevention.Ambulatory Blood Pressure Monitoring (ABPM) as the reference standard for diagnosis of hypertension and assessment of vascular risk in adults.Sleep-time BP: prognostic marker of type 2 diabetes and therapeutic target for prevention.Nocturnal light pollution and underexposure to daytime sunlight: Complementary mechanisms of circadian disruption and related diseases.Ambulatory blood pressure thresholds for diagnosis of hypertension in patients with and without type 2 diabetes based on cardiovascular outcomes.Effects of time-of-day of hypertension treatment on ambulatory blood pressure and clinical characteristics of patients with type 2 diabetes.Effects of exercise and stress management training on nighttime blood pressure dipping in patients with coronary heart disease: A randomized, controlled trial.Diurnal opposite variation between angiotensinase activities in photo-neuro-endocrine tissues of rats.Effects of chronotherapy of benazepril on the diurnal profile of RAAS and clock genes in the kidney of 5/6 nephrectomy rats.
P2860
Q30371562-53E4B9A2-188B-4DD1-89BF-97B9F0F512C9Q34668879-1C4D95CE-D29D-4F60-8A6D-F8FA1DE7B867Q35013404-4468DF7F-A694-4D96-AC5E-72848D65EE93Q36928328-1ADE95A5-A6D5-4CC2-8D25-E47725FD3C24Q37616714-7422098F-28B6-4ABB-9E9B-8D2F8D45597DQ38045901-8C1A8E04-C9AE-408D-9DA5-D588254F84B1Q38045905-DC78DA18-1ECD-4A17-9E99-F0EF512D85DEQ38100986-5D8D5DC7-FE0C-41C5-9628-8347DB332D32Q38110711-F526726A-2BF9-4667-A95D-D85F2D70EEBDQ38177166-A4279D6F-90C6-416E-B35B-4E801E5F2A46Q38185598-4652D1A8-FBF6-47CD-A73A-525CED7A1C3FQ38205097-D60C7079-ED30-4118-B4A6-9AF060E09FC6Q38208966-75D1DA1D-1442-49AF-8C08-8D5125E99FB7Q41328936-0ACDD566-5516-4D49-A116-1B561DD7378AQ41908745-C40F2ACE-2753-4686-B3F8-AE6B83D5E8D8Q44360459-7FC2D01B-E46D-4C94-8837-D0436B7F92F6Q44927482-31442312-4F9B-407F-B916-B8223EF1600AQ45394467-0F1B01EC-0A9E-410C-97DF-A8CA42136D48Q45986217-F221067D-16AB-4751-A38E-8B4748D4031CQ47736556-347537AB-CD96-4006-A4BC-8112FBCC4B5BQ47853674-D002E148-9A2F-44BD-811B-188EE0FE0ABFQ47910182-CEE79F7E-A8DA-47E5-B5C9-A51D78C36D76Q47911570-AF92C3CF-C910-41B8-8F4F-307888BC4D68Q47916747-961A8CCA-A189-4BA7-98AD-5AC8CADBBE2AQ47934068-6E2BE041-2B28-4BA3-8E50-2BD943C743C6Q47936966-2C1A8BC3-5054-4BB5-86CE-B17F20EB1F4FQ48210123-E6D01E19-32C0-43FB-ADC4-2AEBED84C85BQ48210138-E74D8DBC-D050-48B1-9B81-752DFB43DC81Q49294133-4D8E42B7-BF76-48F3-982B-546A4338C647Q50091474-C309AC84-CC94-428B-A26D-E6E449E324B6Q50903440-695C5A22-4CCE-40F0-896A-F558009C8C8B
P2860
Administration-time differences in effects of hypertension medications on ambulatory blood pressure regulation.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Administration-time difference ...... ory blood pressure regulation.
@en
type
label
Administration-time difference ...... ory blood pressure regulation.
@en
prefLabel
Administration-time difference ...... ory blood pressure regulation.
@en
P2093
P2860
P1476
Administration-time difference ...... ory blood pressure regulation.
@en
P2093
Artemio Mojón
Diana E Ayala
Francesco Portaluppi
José R Fernández
Michael H Smolensky
Ramón C Hermida
P2860
P304
P356
10.3109/07420528.2012.709448
P407
P577
2012-10-19T00:00:00Z